Monika Nothacker

Therapeutic modalities for superior sulcus tumor (Pancoast) tumor – A systematic review

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion

S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Kurzversion

S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion

S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Kurzversion

S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0

Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem

S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion

S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0

S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion

S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023

Effect of ICU care bundles on long-term patient-relevant outcomes: a scoping review

Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/091, January 2022)

Automated Monitoring of Adherence to Evidenced-Based Clinical Guideline Recommendations: Design and Implementation Study

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/091, January 2022)

S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“– update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care

S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention

German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023

S3‐Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) – Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care

Use of patient-relevant outcome measures to assess the long-term effects of care bundles in the ICU: a scoping review protocol

Weiterentwicklung und Vernetzung der onkologischen Versorgungsstrukturen, der Qualitätssicherung und der Forschung

Empfehlungen der S3-Leitlinie (AWMF) Einsatz der extrakorporalen Zirkulation (ECLS/ECMO) bei Herz- und Kreislaufversagen

Systemic corticosteroids for the treatment of COVID-19

German S3 Guideline: Oxygen Therapy in the Acute Care of Adult Patients

Use of Extracorporeal Circulation (ECLS/ECMO) for Cardiac and Circulatory Failure –A Clinical Practice Guideline Level 3

Key summary of German national treatment guidance for hospitalized COVID-19 patients